The pharmacokinetics of anthocyanins and their metabolites in humans

R. M. De Ferrars, C. Czank, Q. Zhang, N. P. Botting, P. A. Kroon, A. Cassidy, C. D. Kay*

*Corresponding author for this work

Research output: Contribution to journalArticle

210 Citations (Scopus)
61 Downloads (Pure)

Abstract

Background and Purpose Anthocyanins are phytochemicals with reported vasoactive bioactivity. However, given their instability at neutral pH, they are presumed to undergo significant degradation and subsequent biotransformation. The aim of the present study was to establish the pharmacokinetics of the metabolites of cyanidin-3-glucoside (C3G), a widely consumed dietary phytochemical with potential cardioprotective properties. Experimental Approach A 500-mg oral bolus dose of 6,8,10,3-2,5-2-13C5-C3G was fed to eight healthy male participants, followed by a 48-h collection (0, 0.5, 1, 2, 4, 6, 24, 48-h) of blood, urine and faecal samples. Samples were analysed by HPLC-ESI-MS/MS with elimination kinetics established using non-compartmental pharmacokinetic modelling. Key Results Seventeen 13C-labelled compounds were identified in the serum, including 13C 5-C3G, its degradation products, protocatechuic acid (PCA) and phloroglucinaldehyde (PGA), 13 metabolites of PCA and 1 metabolite derived from PGA. The maximal concentrations of the phenolic metabolites (Cmax) ranged from 10 to 2000-nM, between 2 and 30-h (tmax) post-consumption, with half-lives of elimination observed between 0.5 and 96-h. The major phenolic metabolites identified were hippuric acid and ferulic acid, which peaked in the serum at approximately 16 and 8-h respectively. Conclusions and Implications Anthocyanins are metabolized to a structurally diverse range of metabolites that exhibit dynamic kinetic profiles. Understanding the elimination kinetics of these metabolites is key to the design of future studies examining their utility in dietary interventions or as therapeutics for disease risk reduction.

Original languageEnglish
Pages (from-to)3268-3282
Number of pages15
JournalBritish Journal of Pharmacology
Volume171
Issue number13
DOIs
Publication statusPublished - 10 Jun 2014

Keywords

  • anthocyanins
  • ferulic acid
  • hippuric acid
  • metabolites
  • vanillic acid

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'The pharmacokinetics of anthocyanins and their metabolites in humans'. Together they form a unique fingerprint.

  • Cite this

    De Ferrars, R. M., Czank, C., Zhang, Q., Botting, N. P., Kroon, P. A., Cassidy, A., & Kay, C. D. (2014). The pharmacokinetics of anthocyanins and their metabolites in humans. British Journal of Pharmacology, 171(13), 3268-3282. https://doi.org/10.1111/bph.12676